Hepatitis C Draft Guidance Cites Utility Of Unapproved HCV-RNA Tests
This article was originally published in The Gray Sheet
Executive Summary
Clinical trials of hybridization assays for monitoring hepatitis C viral RNA may use other unapproved HCV-RNA assays to corroborate test results, provided supporting data is submitted, FDA indicates in a recently released draft guidance.